avicenna pharmacare limited
avicenna pharmacare limited Company Information
Company Number
07488002
Next Accounts
Feb 2025
Shareholders
avicenna holdings ltd
Group Structure
View All
Industry
Activities of head offices
Registered Address
selsdon house, 212-220 addington road, south croydon, surrey, CR2 8LD
Website
www.avicenna.orgavicenna pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of AVICENNA PHARMACARE LIMITED at £9.2m based on a Turnover of £16.6m and 0.55x industry multiple (adjusted for size and gross margin).
avicenna pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of AVICENNA PHARMACARE LIMITED at £0 based on an EBITDA of £0 and a 4.26x industry multiple (adjusted for size and gross margin).
avicenna pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of AVICENNA PHARMACARE LIMITED at £2 based on Net Assets of £1 and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avicenna Pharmacare Limited Overview
Avicenna Pharmacare Limited is a dissolved company that was located in south croydon, CR2 8LD with a Companies House number of 07488002. It operated in the activities of head offices sector, SIC Code 70100. Founded in January 2011, it's largest shareholder was avicenna holdings ltd with a 100% stake. The last turnover for Avicenna Pharmacare Limited was estimated at £16.6m.
Upgrade for unlimited company reports & a free credit check
Avicenna Pharmacare Limited Health Check
Pomanda's financial health check has awarded Avicenna Pharmacare Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
5 Weak
Size
annual sales of £16.6m, make it in line with the average company (£18.3m)
- Avicenna Pharmacare Limited
£18.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (2.3%)
- Avicenna Pharmacare Limited
2.3% - Industry AVG
Production
with a gross margin of 18.9%, this company has a higher cost of product (33%)
- Avicenna Pharmacare Limited
33% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Avicenna Pharmacare Limited
- - Industry AVG
Employees
with 45 employees, this is below the industry average (110)
- Avicenna Pharmacare Limited
110 - Industry AVG
Pay Structure
on an average salary of £44.3k, the company has an equivalent pay structure (£44.3k)
- Avicenna Pharmacare Limited
£44.3k - Industry AVG
Efficiency
resulting in sales per employee of £368.1k, this is more efficient (£181.1k)
- Avicenna Pharmacare Limited
£181.1k - Industry AVG
Debtor Days
it gets paid by customers after 85 days, this is later than average (47 days)
- Avicenna Pharmacare Limited
47 days - Industry AVG
Creditor Days
its suppliers are paid after 105 days, this is slower than average (46 days)
- Avicenna Pharmacare Limited
46 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Avicenna Pharmacare Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Avicenna Pharmacare Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a higher level of debt than the average (56.9%)
100% - Avicenna Pharmacare Limited
56.9% - Industry AVG
AVICENNA PHARMACARE LIMITED financials
Avicenna Pharmacare Limited's latest turnover from September 2022 is estimated at £16.6 million and the company has net assets of £1. According to their latest financial statements, we estimate that Avicenna Pharmacare Limited has 45 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | |||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | |||||||
| Gross Profit | 0 | 0 | 0 | 0 | 0 | |||||||
| Admin Expenses | 0 | 0 | 0 | 0 | 0 | |||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | |||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | |||||||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | |||||||
| Pre-Tax Profit | 0 | 0 | 0 | 0 | 0 | |||||||
| Tax | 0 | 0 | 0 | 0 | 0 | |||||||
| Profit After Tax | 0 | 0 | 0 | 0 | 0 | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | |||||||
| Retained Profit | 0 | 0 | 0 | 0 | 0 | |||||||
| Employee Costs | 0 | 0 | 0 | 0 | 0 | |||||||
| Number Of Employees | ||||||||||||
| EBITDA* | 0 | 0 | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,941,344 | 9,644,211 | 6,084,488 | 4,581,797 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,941,344 | 9,644,211 | 6,084,488 | 4,581,797 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 2,294,764 | 1,412,980 | 622,114 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 622,115 | 420,115 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33,474 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 2,294,764 | 1,412,980 | 622,114 | 622,115 | 420,115 | 33,474 |
| total assets | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 3,883,264 | 2,294,764 | 12,354,324 | 10,266,325 | 6,706,603 | 5,001,912 | 33,474 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 2,294,763 | 12,354,323 | 10,266,324 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,706,602 | 5,001,911 | 33,473 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 2,294,763 | 12,354,323 | 10,266,324 | 6,706,602 | 5,001,911 | 33,473 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 3,883,263 | 2,294,763 | 12,354,323 | 10,266,324 | 6,706,602 | 5,001,911 | 33,473 |
| net assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| total shareholders funds | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | |||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | |||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 1,588,500 | 881,784 | 790,866 | -1 | 202,000 | 386,641 | 33,474 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 1,588,500 | -10,059,560 | 2,087,999 | 10,266,324 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -10,941,344 | 1,297,133 | -202,000 | -386,641 | -33,474 | |||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -10,941,344 | 1,297,133 | 3,559,723 | 1,502,691 | 4,581,797 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,706,602 | 1,704,691 | 4,968,438 | 33,473 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | |||||||
| cash flow from financing | 0 | 0 | 1,704,691 | 4,968,438 | 33,474 | |||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
avicenna pharmacare limited Credit Report and Business Information
Avicenna Pharmacare Limited Competitor Analysis
Perform a competitor analysis for avicenna pharmacare limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in CR2 area or any other competitors across 12 key performance metrics.
avicenna pharmacare limited Ownership
AVICENNA PHARMACARE LIMITED group structure
Avicenna Pharmacare Limited has no subsidiary companies.
Ultimate parent company
AVICENNA LTD
#0129150
2 parents
AVICENNA PHARMACARE LIMITED
07488002
avicenna pharmacare limited directors
Avicenna Pharmacare Limited currently has 3 directors. The longest serving directors include Mr Brij Valla (Apr 2023) and Mr Jake Wright (Nov 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Brij Valla | England | 42 years | Apr 2023 | - | Director |
| Mr Jake Wright | England | 52 years | Nov 2023 | - | Director |
| Mr Stewart Graham | 42 years | Feb 2024 | - | Director |
P&L
September 2022turnover
16.6m
0%
operating profit
0
0%
gross margin
19%
+7.61%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2022net assets
1
0%
total assets
3.9m
0%
cash
0
0%
net assets
Total assets minus all liabilities
avicenna pharmacare limited company details
company number
07488002
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
January 2011
age
14
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
September 2022
previous names
N/A
accountant
-
auditor
-
address
selsdon house, 212-220 addington road, south croydon, surrey, CR2 8LD
Bank
HSBC BANK PLC
Legal Advisor
-
avicenna pharmacare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to avicenna pharmacare limited.
avicenna pharmacare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVICENNA PHARMACARE LIMITED. This can take several minutes, an email will notify you when this has completed.
avicenna pharmacare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
